Citations

Mayo Clinic

Showing 10 of 108585 citations.

Immunologic Studies on Cancer of the Upper Aerodigestive Tract
Gustafson, Ray O., Neel, H. Bryan, Pearson, Gary R.

Otolaryngology–Head and Neck Surgery | January 5, 2017 | Volume: 90 | Issue: 1 | Pages: 52-57

10.1177/019459988209000110 | PMID 6283457 Get It

Natural killing (NK) may play an important role in immunosurveillance against virus‐infected and malignant cells. This study has demonstrated that the NK susceptibility of Epstein‐Barr virus (EBV)‐related cell lines increases with increased viral expression within the cells. This finding has implications for surveillance against, and treatment of, EBV‐related disease. Additionally, preliminary studies of the NK status of head and neck cancer patients reveal a distinct clustering of the patients into either groups of high or low NK reactivity. This clustering phenomenon may have a correlation with patient prognosis.
Hearing in Adult‐Onset Diabetes Mellitus
Harner, Stephen G.

Otolaryngology–Head and Neck Surgery | January 5, 2017 | Volume: 89 | Issue: 2 | Pages: 322-327

10.1177/019459988108900235 | PMID 6787535 Get It

Hearing acuity and otologic symptoms were examined in 200 patients with adult‐onset diabetes mellitus. Data were analyzed according to sex and age and were compared with values of other documented studies; values were within normal limits except in two instances. Speech testing revealed that median speech reception thresholds and median discrimination scores were at the lower limits of normal. Hearing loss and otologic problems did not occur with any increased frequency in patients with adult‐onset diabetes mellitus.
Immunologic Detection of Occult Primary Cancer of the Head and Neck
Neel, H. Bryan, Pearson, Gary R., Weiland, Louis H., Taylor, William F., Goepfert, Helmuth

Otolaryngology–Head and Neck Surgery | January 5, 2017 | Volume: 89 | Issue: 2 | Pages: 230-234

10.1177/019459988108900217 | PMID 6264367 Get It

Because antibody titers against Epstein‐Barr virus (EBV) antigens often are elevated in patients with active undifferentiated and nonkeratinizing nasopharyngeal carcinoma, anti‐EBV serologic tests have been applied as a diagnostic aid in patients who have metastatic lymphadenopathy in the neck without an obvious source. In this study of 44 patients, the serologic testing procedure proved useful in identifying six patients with nasopharyngeal carcinoma that was initially occult but was eventually confirmed by biopsy.
Reply
Blum, Daniel

Otolaryngology–Head and Neck Surgery | January 5, 2017 | Volume: 92 | Issue: 1 | Pages: 124-124

10.1177/019459988409200129 Get It

A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking
Froehlich, Janice C., Fischer, Stephen M. , Nicholson, Emily R., Dilley, Julian E. , Filosa, Nicholas J., Smith, Teal N., Rademacher, Logan C.

Alcoholism: Clinical and Experimental Research | January 5, 2017 | Volume: 41 | Issue: 3 | Pages: 644-652

10.1111/acer.13326 | PMID 28055135 Get It

Malignant Pyoderma
Salassa, John R., Winkelmann, R.K., McDonald, Thomas J.

Otolaryngology–Head and Neck Surgery | January 5, 2017 | Volume: 89 | Issue: 6 | Pages: 917-922

10.1177/019459988108900608 | PMID 6801591 Get It

Malignant pyoderma is a rare inflammatory pyoderma of unknown cause with characteristic destructive and necrotizing ulcers limited to the face, neck, and upper trunk. The typical lesions are small, purulent, periauricular ulcers. Enlargement and coalescence result in extensive lesions that may ultimately destroy portions of the external ear. The histopathologic findings are acute and chronic inflammation with necrosis. Treatment consists of long‐term systemic corticosteroids. We present two new cases and alert otolaryngologists to the seriousness of this disease.
P-011 Imaging and Histopathology of Thrombi in Acute Ischemic Stroke: Systematic Review and Meta-analysis
Brinjikji, Waleed , Duffy, Sharon , Kallmes, David F.

Oral poster abstracts | January 5, 2017 | Volume: No volume available | Issue: No issue available | Pages: A33.1-A33

10.1136/neurintsurg-2016-012589.53 Get It

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
Himelstein, Andrew L., Foster, Jared C. , Khatcheressian, James, Roberts, John D. , Seisler, Drew K., Novotny, Paul J. , Qin, Rui , Grubbs, Stephen S., O’Connor, Tracey L. , Velasco, Mario R. , Weckstein, Douglas, O’Mara, Ann M., Loprinzi, Charles L. , Go, Ronald S. , Shapiro, Charles L.

JAMA | January 5, 2017 | Volume: 317 | Issue: 1 | Pages: 48

10.1001/jama.2016.19425 | PMID 28030702 Get It

Clinical features of shiitake dermatitis: a systematic review
Nguyen, Austin Huy , Gonzaga, Maria I., Lim, Victoria M. , Adler, Michael J., Mitkov, Mario , Cappel, Mark A. , Mitkov, Mario V.

International Journal of Dermatology | January 5, 2017 | Volume: 56 | Issue: 6 | Pages: 610-616

10.1111/ijd.13433 | PMID 28054338 Get It

SummaryShiitake dermatitis is a rare cutaneous reaction to lentinan, a polysaccharide component in the cell walls of shiitake mushrooms (Lentinula edodes). Herein, we systematically review the case report and case series English‐language literature on shiitake dermatitis, which refers to a total of 50 patients (38 males, 12 females; mean age: 44.58 years). The majority of cases occurred after the consumption of raw mushrooms, whereas 22% of cases were caused by the eating of lightly or undercooked mushrooms. The most common clinical presentations, localized symptoms, and systemic findings include linear flagellated dermatitis (98%), pruritus (78%), and fever, diarrhea, and mucosal ulcers, respectively. The diagnosis of this entity continues to be based on clinical findings as laboratory abnormalities, and the findings of skin biopsies and patch/prick tests are nonspecific and inconsistent. The condition is self‐limiting, resolving in approximately 12.5 d without treatment. Based on the included case reports, it appears that medical treatment may slightly shorten the course of disease (to 9–11 d, varying by therapy) but should be considered on an individual patient basis. However, the treatment of symptoms, reassurance, and the avoidance of re‐exposure are sufficient treatment recommendations for this condition.
Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer
Walz, Amy L. , Ugolkov, Andrey , Chandra, Sunandana , Kozikowski, Alan P. , Carneiro, Benedito A. , O’Halloran, Thomas V. , Billadeau, Daniel D. , Mazar, Andrew P. , Giles, Francis Joseph

Clinical Cancer Research | January 5, 2017 | Volume: 23 | Issue: 8 | Pages: 1891-1897

10.1158/1078-0432.ccr-15-2240 | PMID 28053024 Get It

Abstract Glycogen synthase kinase-3β (GSK-3β), a serine/threonine protein kinase, is a complex regulator of numerous cellular functions. GSK-3β is a unique kinase which is constitutively active in resting and nonstimulated cells. GSK-3β has been implicated in a wide range of diseases including neurodegeneration, inflammation and fibrosis, noninsulin-dependent diabetes mellitus, and cancer. It is a regulator of NF-κB–mediated survival of cancer cells, which provided a rationale for the development of GSK-3 inhibitors targeting malignant tumors. Recent studies, many of them reported over the past decade, have identified GSK-3β as a potential therapeutic target in more than 15 different types of cancer. Whereas only active GSK-3β is expressed in cancer cell nucleus, aberrant nuclear accumulation of GSK-3β has been identified as a hallmark of cancer cells in malignant tumors of different origin. This review focuses on the preclinical and clinical development of GSK-3 inhibitors and the potential therapeutic impact of targeting GSK-3β in human cancer. Clin Cancer Res; 23(8); 1891–7. ©2017 AACR.